BREAST CANCER GENES INCLUDED IN NEW TEST
<p><b>Pathway to market DNA screening that looks for mutations</b></p>
<p>A new cancer test from San Diego-based Pathway Genomics will include results for two breast cancer genes formerly patented by Myriad Genetics. A Supreme Court decision on Thursday invalidated those and other patents on naturally occurring DNA.</p>
<p>Pathway’s Hereditary Cancer DNA Insight test will go on sale in August, said CEO Jim Plante. The test will screen for mutations in more than 30 genes involved in breast, ovarian, colorectal and other cancers.</p>
